A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/9531956

Download in:

View as

General Info

PMID
9531956